Journal Club: Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration
Striatech is pleased to announce its upcoming Journal Club session, “Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration,” which
Read moreStriatech is pleased to announce its upcoming Journal Club session, “Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration,” which
Read moreAstraZeneca has acquired Modella AI, as announced by the Boston-based artificial intelligence company on Tuesday. Focused on life sciences, the
Read moreNimbus Therapeutics has entered into a multi-year research collaboration and exclusive worldwide license agreement with Eli Lilly and Company to
Read moreSanofi has announced it has agreed to acquire Dynavax Technologies Corporation, a publicly traded vaccines company, in a move that
Read moreNovo Nordisk A/S has announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral
Read moreThe new Huntsville, Alabama site will produce small molecule and peptide medicines, including oral GLP-1 orforglipron Eli Lilly and Company
Read moreStriatech is pleased to announce its next Journal Club: Gene-Agnostic Gene Therapy to Preserve Vision, which will be held on
Read moreMerck & Co., Inc. announced on Monday a sweeping expansion of its U.S. operations, pledging more than $70 Billion in
Read morePfizer Inc. has reached a sweeping agreement with the Trump Administration that will reduce prescription drug costs for U.S. patients
Read moreAstraZeneca, the Anglo-Swedish pharmaceutical giant, announced on Monday, plans to harmonise its share listing structure across the London Stock Exchange
Read more